Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Regen BioPharma Inc
RGBP
Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. It is involved on mRNA and small molecule therapies for treating cancer and autoimmune disorders. It is also developing products treating blood disorders using small molecules and...
gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax, tCellVax, Dura-CAR, KimerApt), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate). HemaXellerate is a personalized cellular therapeutic product designed to stimulate blood production in patients. tCellVax is a cell-based immunotherapy that stimulates the patient’s immune system through gene silencing of NR2F6.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:RGBP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 10, 2023 8:00am
New Press Release - Regen BioPharma, Inc. Receives First Phase of Confirmatory Study
CAR-T Cells CreatedSAN DIEGO, Oct. 10, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its DuraCAR CAR T-cell therapeutic (https://www.prnewswire.com/news-releases/regen-biopharma-inc--begins...
read article.
(5)
•••
MasterJedijazz
X
View Profile
View Bullboard History
Post by
MasterJedijazz
on Oct 09, 2023 8:49am
$RGBP Undervalued PT $5 with $17M Market Cap
$RGBP Upcoming milestones include new CRO confirmatory study results, animal studies, and an IND submission. The IND submission could lead to a Phase I clinical (human) trial in 18+ months. Our 6-12
...more
Oil & Gas Co. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition, Transformational Debt Recapitalization, $150 Million RBL Commitment and a $100 Million Bought Deal Equity Financing
posted May 08, 2024 9:00am by
Saturn Oil & Gas Inc.
-
|
"The Acquired Assets are a perfect fit with Saturn's existing Saskatchewan operations and offer meaningful synergies. The Acquisition is highly accretive for our shareholders and consistent with our strategy of acquiring quality assets where we can apply our strategic operating approach to enhance margins, grow Adjusted EBITDA(3) and increase Free Funds Flow ...read more
(7)
•••
Tdogzz18
X
View Profile
View Bullboard History
Post by
Tdogzz18
on Oct 09, 2023 8:44am
Goldman Small Cap Research Publishes RGBP.
https://www.marketwatch.com/press-release/goldman-small-cap-research-publishes-new-research-report-on-regen-biopharma-inc-fe695ae1?mod=mw_quote_news_seemore
(5)
•••
MasterJedijazz
X
View Profile
View Bullboard History
Comment by
MasterJedijazz
on Oct 09, 2023 8:43am
RE:Goldman Small Cap Research Publishes New Research Report on
Excellent research report $RGBP
(7)
•••
Tdogzz18
X
View Profile
View Bullboard History
Post by
Tdogzz18
on Oct 09, 2023 8:40am
Goldman Small Cap Research Publishes New Research Report on
https://www.goldmanresearch.com/202310041385/Opportunity-Research/an-emerging-cancer-and-autoimmune-player.html
(11)
•••
Stockhunter101
X
View Profile
View Bullboard History
Post by
Stockhunter101
on Oct 09, 2023 8:23am
#NewReport on @TheRegenBio $RGBP
A new study report on Regen BioPharma, Inc. (OTCPK:RGBP) was released by Goldman Small Cap study, a stock market research company that specializes in the small cap and microcap sectors. Regen may be
...more
(11)
•••
Stockhunter101
X
View Profile
View Bullboard History
Post by
Stockhunter101
on Oct 09, 2023 8:20am
#NewReport on @TheRegenBio $RGBP
[img]https://sih-st-charts.stocktwits-cdn.com/fit-in/500x0/filters:quality(75)/production/original_547179859.jpg[/img] A new study report on Regen BioPharma, Inc. (OTCPK:RGBP) was released by
...more
(92)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 06, 2023 8:45pm
Regen BioPharma, Inc. to Present at the Emerging Growth Conf
News; $RGBP Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023 PR Newswire
...more
(2)
•••
HampsStockstar
X
View Profile
View Bullboard History
Post by
HampsStockstar
on Aug 31, 2021 2:30pm
$RGBP $LRSV & $LCLP in new article out
RGBP new 8k out & no dilution. Article out yesterday with $LRSV $LCLP on 3 Otc Stocks To Watch 3 OTC Stocks That Should Be On Top Of Your Watchlist | MomentumObserver.com
(2)
•••
HampsStockstar
X
View Profile
View Bullboard History
Post by
HampsStockstar
on Aug 27, 2021 2:16am
Article says $RGBP $LRSV $CYBL 500% potential upside
Nice read out on Fast Money Leaks 3 OTC Stocks With UP to 500% Gain Potential | FastMoneyLeaks.com
(99)
•••
rockingrooster
X
View Profile
View Bullboard History
Post by
rockingrooster
on Aug 17, 2021 10:51am
NEW PATENT GRANTED....AMAZING
https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332
(0)
•••
bay8605
X
View Profile
View Bullboard History
Post by
bay8605
on Apr 10, 2021 5:49pm
Regen Biopharma
https://insiderfinancial.com/regen-biopharma-about-to-become-a-major-pharma-player/181241/amp/?__twitter_impression=true
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold